Experts stress the need to improve access to health care in India

19 September 2011

Providing adequate access to medicines and health care is one of the most challenging issues being faced by India today. While scientific knowledge and health care products and services have advanced exponentially over the last generation, millions of people in India still die from preventable and curable diseases because they lack access to basic medicines and medical services.

Disparities in health and health care remain pervasive and problematic. The World Health Organization estimates that only 35% of India’s population is able to get essential drugs for common diseases, warn experts in a prepared statement.

Despite 60 years of independence, majority of citizens have very limited access to quality health care and have poor health indicators like low levels of immunization and high infant mortality rates. More than a million Indians die each year due to lack of proper treatment, most of them being women and children. Furthermore, poor health impedes individuals’ ability to seek educational opportunities, to attain regular employment and to reach full life spans, they say.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics